Literature DB >> 17229944

Effect of ruboxistaurin on urinary transforming growth factor-beta in patients with diabetic nephropathy and type 2 diabetes.

Richard E Gilbert1, Sandra A Kim, Katherine R Tuttle, George L Bakris, Robert D Toto, Janet B McGill, Douglas J Haney, Darren J Kelly, Pamela W Anderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17229944     DOI： 10.2337/dc06-2079

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  21 in total

Review 1.  Targeting inflammation in diabetes: Newer therapeutic options.

Authors:  Neeraj Kumar Agrawal; Saket Kant
Journal:  World J Diabetes       Date:  2014-10-15

Review 2.  New pharmacological treatments for improving renal outcomes in diabetes.

Authors:  Anne-Emilie Declèves; Kumar Sharma
Journal:  Nat Rev Nephrol       Date:  2010-05-04       Impact factor: 28.314

3.  The effect of renal hyperfiltration on urinary inflammatory cytokines/chemokines in patients with uncomplicated type 1 diabetes mellitus.

Authors:  R Har; J W Scholey; D Daneman; F H Mahmud; R Dekker; V Lai; Y Elia; M L Fritzler; E B Sochett; H N Reich; D Z I Cherney
Journal:  Diabetologia       Date:  2013-02-15       Impact factor: 10.122

Review 4.  The New Biology of Diabetic Kidney Disease-Mechanisms and Therapeutic Implications.

Authors:  Yuliya Lytvyn; Petter Bjornstad; Daniel H van Raalte; Hiddo L Heerspink; David Z I Cherney
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

Review 5.  Oxidative stress in early diabetic nephropathy: fueling the fire.

Authors:  Dhruv K Singh; Peter Winocour; Ken Farrington
Journal:  Nat Rev Endocrinol       Date:  2010-12-14       Impact factor: 43.330

Review 6.  Targeting the protein kinase C family in the diabetic kidney: lessons from analysis of mutant mice.

Authors:  M Meier; J Menne; H Haller
Journal:  Diabetologia       Date:  2009-02-24       Impact factor: 10.122

Review 7.  Therapeutic approaches to diabetic nephropathy--beyond the RAS.

Authors:  Beatriz Fernandez-Fernandez; Alberto Ortiz; Carmen Gomez-Guerrero; Jesus Egido
Journal:  Nat Rev Nephrol       Date:  2014-05-06       Impact factor: 28.314

Review 8.  Implications of treatment that target protective mechanisms against diabetic nephropathy.

Authors:  Akira Mima; Weier Qi; George L King
Journal:  Semin Nephrol       Date:  2012-09       Impact factor: 5.299

Review 9.  Therapies on the Horizon for Diabetic Kidney Disease.

Authors:  Sadaf S Khan; Susan E Quaggin
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

10.  Effects of a GSK-3β inhibitor on the renal expression levels of RANK, RANKL and NF-κB in a rat model of diabetic nephropathy.

Authors:  Yi-Xia Zhou; Li-Xin Shi; Hua Yang; Yi-Guo Long; L U Meng; Li-Sa Lv; Yang Zhang; Huan Yao; Long Li; Yan-Ni Yu
Journal:  Exp Ther Med       Date:  2016-03-24       Impact factor: 2.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.